Suppr超能文献

中等射血分数患者中传导系统起搏与双心室起搏的临床结局比较。

Clinical outcomes of conduction system pacing compared to biventricular pacing in patients with mid-range ejection fraction.

作者信息

Tang Jiaojiao, Kong Nathan W, Beaser Andrew, Aziz Zaid, Yeshwant Srinath, Ozcan Cevher, Tung Roderick, Upadhyay Gaurav A

机构信息

Center for Arrhythmia Care, Heart and Vascular Institute, The University of Chicago Pritzker School of Medicine, 5841 S. Maryland Avenue, MC 9024, Chicago, IL, 60637, USA.

The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.

出版信息

J Interv Card Electrophysiol. 2025 Jan;68(1):111-116. doi: 10.1007/s10840-024-01882-z. Epub 2024 Aug 17.

Abstract

BACKGROUND

There is a paucity of data comparing conduction system pacing (CSP) to biventricular pacing (BiVP) in patients with heart failure (HF) with mid-range left ventricular ejection fraction (LVEF).

OBJECTIVE

Compare the clinical outcomes of patients with mid-range LVEF undergoing CSP versus BiVP.

METHODS

Patients with mid-range LVEF (> 35 to 50%) undergoing CSP or BiVP were retrospectively identified. Lead performance, LVEF, HF hospitalization, and clinical composite outcome including upgrade to cardiac resynchronization therapy and mortality were compared.

RESULTS

A total of 36 patients (20 BiVP, 16 CSP--14 His bundle pacing, 4 left bundle branch area pacing) were analyzed. The mean age was 73 ± 15, 44% were female, and the mean LVEF was 42 ± 5%. Procedural and fluoroscopy time was comparable between the two groups. QRS duration was significantly shorter for the CSP group compared to the BiVP group (P < 0.001). During a mean follow-up of 47 ± 36 months, no significant differences were found in thresholds or need for generator change due to early battery depletion. LVEF improved in both groups (41.5 ± 4.5% to 53.9 ± 10.9% BiVP, P < 0.001; 41.6 ± 5.3% to 52.5 ± 8.3% CSP, P < 0.001). There were no significant differences in HF hospitalizations (P = 0.71) or clinical composite outcomes (P = 0.07).

CONCLUSION

Among patients with HF with moderately reduced ejection fraction, CSP appears associated with similar improvements in LVEF and had similar clinical outcomes as BiVP in mid-term follow-up.

摘要

背景

在左心室射血分数(LVEF)中等的心力衰竭(HF)患者中,比较传导系统起搏(CSP)与双心室起搏(BiVP)的数据较少。

目的

比较接受CSP与BiVP治疗的LVEF中等的患者的临床结局。

方法

回顾性确定接受CSP或BiVP治疗的LVEF中等(>35%至50%)的患者。比较导线性能、LVEF、心力衰竭住院情况以及包括升级为心脏再同步治疗和死亡率在内的临床综合结局。

结果

共分析了36例患者(20例BiVP,16例CSP——14例希氏束起搏,4例左束支区域起搏)。平均年龄为73±15岁,44%为女性,平均LVEF为42±5%。两组的手术时间和透视时间相当。与BiVP组相比,CSP组的QRS时限明显更短(P<0.001)。在平均47±36个月的随访期间,两组在阈值或因早期电池耗尽而需要更换发生器方面没有显著差异。两组的LVEF均有所改善(BiVP组从41.5±4.5%提高到53.9±10.9%,P<0.001;CSP组从41.6±5.3%提高到52.5±8.3%,P<0.001)。心力衰竭住院情况(P=0.71)或临床综合结局(P=0.07)没有显著差异。

结论

在射血分数中度降低的心力衰竭患者中,CSP在中期随访中似乎与LVEF的改善相似,且临床结局与BiVP相似。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验